Cargando…
The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
Given the high risk of lung cancer (LC) in patients with combined pulmonary fibrosis and emphysema (CPFE), and the difficulty of early diagnosis, it is important to understand the impact of LC in these patients. The effect of LC on the development of acute exacerbation (AE) as a natural course of CP...
Autores principales: | Feng, Xiaoyi, Duan, Yishan, Lv, Xiafei, Li, Qinxue, Liang, Binmiao, Ou, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917551/ https://www.ncbi.nlm.nih.gov/pubmed/36769748 http://dx.doi.org/10.3390/jcm12031100 |
Ejemplares similares
-
Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management
por: Hage, René, et al.
Publicado: (2021) -
Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Papaioannou, Andriana I., et al.
Publicado: (2016) -
The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Choi, Seung Hee, et al.
Publicado: (2014) -
IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE)
por: Kono, Masato, et al.
Publicado: (2018) -
The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
por: Kinjo, Takumi, et al.
Publicado: (2020)